Target Price | $14.30 |
Price | $11.25 |
Potential |
27.09%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target Nubank 2026 .
The average Nubank target price is $14.30.
This is
27.09%
register free of charge
$19.27
71.25%
register free of charge
$8.90
20.89%
register free of charge
|
|
A rating was issued by 20 analysts: 10 Analysts recommend Nubank to buy, 7 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nubank stock has an average upside potential 2026 of
27.09%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 10.33 | 12.48 |
47.34% | 20.83% | |
Net Margin | 19.12% | 20.40% |
26.49% | 6.67% |
15 Analysts have issued a sales forecast Nubank 2025 . The average Nubank sales estimate is
This results in the following potential growth metrics:
8 Nubank Analysts have issued a net profit forecast 2025. The average Nubank net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.41 | 0.53 |
86.36% | 29.27% | |
P/E | 21.28 | |
EV/Sales | 3.59 |
8 Analysts have issued a Nubank forecast for earnings per share. The average Nubank <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Nubank stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays | Locked ➜ Locked | Locked | Feb 24 2025 |
JP Morgan | Locked ➜ Locked | Locked | Feb 24 2025 |
UBS | Locked ➜ Locked | Locked | Feb 18 2025 |
Citigroup | Locked ➜ Locked | Locked | Dec 02 2024 |
Goldman Sachs | Locked ➜ Locked | Locked | Nov 14 2024 |
Keybanc | Locked ➜ Locked | Locked | Nov 14 2024 |
Susquehanna | Locked ➜ Locked | Locked | Nov 14 2024 |
Analyst Rating | Date |
---|---|
Locked
Barclays: Locked ➜ Locked
|
Feb 24 2025 |
Locked
JP Morgan: Locked ➜ Locked
|
Feb 24 2025 |
Locked
UBS: Locked ➜ Locked
|
Feb 18 2025 |
Locked
Citigroup: Locked ➜ Locked
|
Dec 02 2024 |
Locked
Goldman Sachs: Locked ➜ Locked
|
Nov 14 2024 |
Locked
Keybanc: Locked ➜ Locked
|
Nov 14 2024 |
Locked
Susquehanna: Locked ➜ Locked
|
Nov 14 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.